Notably DM/CADM patients with antimelanoma differentiation‐associated gene 5 (anti‐MDA5) antibody positive frequently develop a rapidly progressive form of ILD with fatal outcome.5 Here, IFIH1 is linked to clinically amyopathic dermatomyositis.